▶ 調査レポート

世界のイソクエン酸デヒドロゲナーゼ阻害剤市場:専門的調査

• 英文タイトル:Global Isocitrate Dehydrogenase Inhibitors Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界のイソクエン酸デヒドロゲナーゼ阻害剤市場:専門的調査 / Global Isocitrate Dehydrogenase Inhibitors Market Professional Survey Report 2019 / QYR9ST14001資料のイメージです。• レポートコード:QYR9ST14001
• 出版社/出版日:QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、119ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、IDH1変異髄様悪性腫瘍、IDH2変異髄様悪性腫瘍、その他に、用途別には、DH阻害剤、FLT3阻害剤、ハリネズミ経路阻害剤、その他にセグメント区分し、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・イソクエン酸デヒドロゲナーゼ阻害剤の世界市場概要
・イソクエン酸デヒドロゲナーゼ阻害剤の製造コスト構成分析
・イソクエン酸デヒドロゲナーゼ阻害剤の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・イソクエン酸デヒドロゲナーゼ阻害剤の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・イソクエン酸デヒドロゲナーゼ阻害剤のセグメント分析(種類別)
(IDH1変異髄様悪性腫瘍、IDH2変異髄様悪性腫瘍、その他)
・イソクエン酸デヒドロゲナーゼ阻害剤のセグメント分析(用途別)
(DH阻害剤、FLT3阻害剤、ハリネズミ経路阻害剤、その他)
・イソクエン酸デヒドロゲナーゼ阻害剤の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(AGIOS、Aslan Pharmaceuticals、Bayer、Beigene、Bristol-Myers Squibb、Celgene、Daiichi Sankyo、Philogen S.p.A.、Tesaro、Tragara/Adastra、Tocagen)
・イソクエン酸デヒドロゲナーゼ阻害剤の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.

The global Isocitrate Dehydrogenase Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Isocitrate Dehydrogenase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Isocitrate Dehydrogenase Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Isocitrate Dehydrogenase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Isocitrate Dehydrogenase Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AGIOS
Aslan Pharmaceuticals
Bayer
Beigene
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Philogen S.p.A.
Tesaro
Tragara/Adastra
Tocagen

Segment by Regions
North America
Europe
China
Japan

Segment by Type
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others

Segment by Application
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Isocitrate Dehydrogenase Inhibitors
1.1 Definition of Isocitrate Dehydrogenase Inhibitors
1.2 Isocitrate Dehydrogenase Inhibitors Segment by Type
1.2.1 Global Isocitrate Dehydrogenase Inhibitors Production Growth Rate Comparison by Types (2014-2025)
1.2.2 IDH1 Mutant Medullary Malignant Tumor
1.2.3 IDH2 Mutant Medullary Malignant Tumor
1.2.4 Others
1.3 Isocitrate Dehydrogenase Inhibitors Segment by Applications
1.3.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Comparison by Applications (2014-2025)
1.5.2 DH Inhibitor
1.5.3 FLT3 Inhibitor
1.5.4 Hedgehog Pathway Inhibitor
1.5.5 Others
1.4 Global Isocitrate Dehydrogenase Inhibitors Overall Market
1.4.1 Global Isocitrate Dehydrogenase Inhibitors Revenue (2014-2025)
1.4.2 Global Isocitrate Dehydrogenase Inhibitors Production (2014-2025)
1.4.3 North America Isocitrate Dehydrogenase Inhibitors Status and Prospect (2014-2025)
1.4.4 Europe Isocitrate Dehydrogenase Inhibitors Status and Prospect (2014-2025)
1.4.5 China Isocitrate Dehydrogenase Inhibitors Status and Prospect (2014-2025)
1.4.6 Japan Isocitrate Dehydrogenase Inhibitors Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Isocitrate Dehydrogenase Inhibitors
2.3 Manufacturing Process Analysis of Isocitrate Dehydrogenase Inhibitors
2.4 Industry Chain Structure of Isocitrate Dehydrogenase Inhibitors

3 Development and Manufacturing Plants Analysis of Isocitrate Dehydrogenase Inhibitors
3.1 Capacity and Commercial Production Date
3.2 Global Isocitrate Dehydrogenase Inhibitors Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Isocitrate Dehydrogenase Inhibitors
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Isocitrate Dehydrogenase Inhibitors Production and Capacity Analysis
4.2 Isocitrate Dehydrogenase Inhibitors Revenue Analysis
4.3 Isocitrate Dehydrogenase Inhibitors Price Analysis
4.4 Market Concentration Degree

5 Isocitrate Dehydrogenase Inhibitors Regional Market Analysis
5.1 Isocitrate Dehydrogenase Inhibitors Production by Regions
5.1.1 Global Isocitrate Dehydrogenase Inhibitors Production by Regions
5.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue by Regions
5.2 Isocitrate Dehydrogenase Inhibitors Consumption by Regions
5.3 North America Isocitrate Dehydrogenase Inhibitors Market Analysis
5.3.1 North America Isocitrate Dehydrogenase Inhibitors Production
5.3.2 North America Isocitrate Dehydrogenase Inhibitors Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Isocitrate Dehydrogenase Inhibitors Import and Export
5.4 Europe Isocitrate Dehydrogenase Inhibitors Market Analysis
5.4.1 Europe Isocitrate Dehydrogenase Inhibitors Production
5.4.2 Europe Isocitrate Dehydrogenase Inhibitors Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Isocitrate Dehydrogenase Inhibitors Import and Export
5.5 China Isocitrate Dehydrogenase Inhibitors Market Analysis
5.5.1 China Isocitrate Dehydrogenase Inhibitors Production
5.5.2 China Isocitrate Dehydrogenase Inhibitors Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Isocitrate Dehydrogenase Inhibitors Import and Export
5.6 Japan Isocitrate Dehydrogenase Inhibitors Market Analysis
5.6.1 Japan Isocitrate Dehydrogenase Inhibitors Production
5.6.2 Japan Isocitrate Dehydrogenase Inhibitors Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Isocitrate Dehydrogenase Inhibitors Import and Export

6 Isocitrate Dehydrogenase Inhibitors Segment Market Analysis (by Type)
6.1 Global Isocitrate Dehydrogenase Inhibitors Production by Type
6.2 Global Isocitrate Dehydrogenase Inhibitors Revenue by Type
6.3 Isocitrate Dehydrogenase Inhibitors Price by Type

7 Isocitrate Dehydrogenase Inhibitors Segment Market Analysis (by Application)
7.1 Global Isocitrate Dehydrogenase Inhibitors Consumption by Application
7.2 Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Application (2014-2019)

8 Isocitrate Dehydrogenase Inhibitors Major Manufacturers Analysis
8.1 AGIOS
8.1.1 AGIOS Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.1.2 AGIOS Product Introduction, Application and Specification
8.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Aslan Pharmaceuticals
8.2.1 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.2.2 Aslan Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer
8.3.1 Bayer Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.3.2 Bayer Product Introduction, Application and Specification
8.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Beigene
8.4.1 Beigene Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.4.2 Beigene Product Introduction, Application and Specification
8.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.5.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Celgene
8.6.1 Celgene Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.6.2 Celgene Product Introduction, Application and Specification
8.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Daiichi Sankyo
8.7.1 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.7.2 Daiichi Sankyo Product Introduction, Application and Specification
8.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Philogen S.p.A.
8.8.1 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.8.2 Philogen S.p.A. Product Introduction, Application and Specification
8.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Tesaro
8.9.1 Tesaro Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.9.2 Tesaro Product Introduction, Application and Specification
8.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Tragara/Adastra
8.10.1 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
8.10.2 Tragara/Adastra Product Introduction, Application and Specification
8.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Tocagen

9 Development Trend of Analysis of Isocitrate Dehydrogenase Inhibitors Market
9.1 Global Isocitrate Dehydrogenase Inhibitors Market Trend Analysis
9.1.1 Global Isocitrate Dehydrogenase Inhibitors Market Size (Volume and Value) Forecast 2019-2025
9.2 Isocitrate Dehydrogenase Inhibitors Regional Market Trend
9.2.1 North America Isocitrate Dehydrogenase Inhibitors Forecast 2019-2025
9.2.2 Europe Isocitrate Dehydrogenase Inhibitors Forecast 2019-2025
9.2.3 China Isocitrate Dehydrogenase Inhibitors Forecast 2019-2025
9.2.4 Japan Isocitrate Dehydrogenase Inhibitors Forecast 2019-2025
9.3 Isocitrate Dehydrogenase Inhibitors Market Trend (Product Type)
9.4 Isocitrate Dehydrogenase Inhibitors Market Trend (Application)

10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Isocitrate Dehydrogenase Inhibitors Distributors List
10.3 Isocitrate Dehydrogenase Inhibitors Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Isocitrate Dehydrogenase Inhibitors
Table Global Isocitrate Dehydrogenase Inhibitors Production (Kg) Growth Rate Comparison by Types (2014-2025)
Figure Global Isocitrate Dehydrogenase Inhibitors Production Market Share by Types in 2018
Figure IDH1 Mutant Medullary Malignant Tumor Product Picture
Figure IDH2 Mutant Medullary Malignant Tumor Product Picture
Figure Others Product Picture
Table Global Isocitrate Dehydrogenase Inhibitors Consumption (Kg) Comparison by Applications (2014-2025)
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Applications in 2018
Figure DH Inhibitor
Figure FLT3 Inhibitor
Figure Hedgehog Pathway Inhibitor
Figure Others
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue (Million USD) (2014-2025)
Figure Global Isocitrate Dehydrogenase Inhibitors Production (Kg) (2014-2025)
Figure North America Isocitrate Dehydrogenase Inhibitors Market Size (Million USD) (2014-2025)
Figure Europe Isocitrate Dehydrogenase Inhibitors Market Size (Million USD) (2014-2025)
Figure China Isocitrate Dehydrogenase Inhibitors Market Size (Million USD) (2014-2025)
Figure Japan Isocitrate Dehydrogenase Inhibitors Market Size (Million USD) (2014-2025)
Table Manufacturing Cost Structure Analysis of Isocitrate Dehydrogenase Inhibitors in 2018
Figure Manufacturing Process Analysis of Isocitrate Dehydrogenase Inhibitors
Figure Industry Chain Structure of Isocitrate Dehydrogenase Inhibitors
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Isocitrate Dehydrogenase Inhibitors Manufacturing Plants Distribution
Table Isocitrate Dehydrogenase Inhibitors Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Isocitrate Dehydrogenase Inhibitors Capacity (Kg) of Major Manufacturers (2014-2019)
Table Isocitrate Dehydrogenase Inhibitors Production (Kg) of Major Manufacturers (2014-2019)
Table Isocitrate Dehydrogenase Inhibitors Production Market Share of Major Manufacturers (2014-2019)
Figure Isocitrate Dehydrogenase Inhibitors Production Share by Manufacturers in 2018
Table Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Isocitrate Dehydrogenase Inhibitors Revenue Market Share of Major Manufacturers (2014-2019)
Figure Isocitrate Dehydrogenase Inhibitors Revenue Share by Manufacturers in 2018
Table Isocitrate Dehydrogenase Inhibitors Average Price (USD/g) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Isocitrate Dehydrogenase Inhibitors Production by Regions 2014-2019 (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Production Market Share by Regions 2014-2019
Figure Global Isocitrate Dehydrogenase Inhibitors Production Market Share by Regions in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Regions 2014-2019 (Million USD)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Regions in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Consumption by Regions 2014-2019 (Kg)
Table Global Isocitrate Dehydrogenase Inhibitors Consumption Market Share by Regions 2014-2019
Figure North America Isocitrate Dehydrogenase Inhibitors Production Growth Rate 2014-2019 (Kg)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table North America Isocitrate Dehydrogenase Inhibitors Production, Consumption Import and Export (Kg)
Figure Europe Isocitrate Dehydrogenase Inhibitors Production Growth Rate 2014-2019 (Kg)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Isocitrate Dehydrogenase Inhibitors Production, Consumption Import and Export (Kg)
Figure China Isocitrate Dehydrogenase Inhibitors Production Growth Rate 2014-2019 (Kg)
Figure China Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table China Isocitrate Dehydrogenase Inhibitors Production, Consumption Import and Export (Kg)
Figure Japan Isocitrate Dehydrogenase Inhibitors Production Growth Rate 2014-2019 (Kg)
Figure Japan Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Isocitrate Dehydrogenase Inhibitors Production, Consumption Import and Export (Kg)
Figure Global Consumption Isocitrate Dehydrogenase Inhibitors Market Share by Application (2014-2019)
Figure Global Value (Consumption) Isocitrate Dehydrogenase Inhibitors Market Share by Application (2014-2019)
Table AGIOS Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table AGIOS Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table AGIOS Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table AGIOS Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table AGIOS Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure AGIOS Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table AGIOS Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Bayer Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Bayer Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Bayer Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Bayer Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Bayer Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Bayer Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Bayer Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Beigene Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Beigene Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Beigene Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Beigene Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Beigene Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Beigene Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Beigene Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Celgene Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Celgene Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Celgene Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Celgene Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Celgene Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Celgene Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Celgene Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Tesaro Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Tesaro Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Tesaro Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Tesaro Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Tesaro Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Tesaro Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Tesaro Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production (Kg), Revenue (Million USD), Ex-factory Price (USD/g) and Gross Margin (2014-2019)
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production Growth Rate (2014-2019)
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Production Market Share (2014-2019)
Figure Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue Market Share (2014-2019)
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Main Business and Markets Served
Table Tocagen Isocitrate Dehydrogenase Inhibitors Production Sites and Area Served
Figure Global Isocitrate Dehydrogenase Inhibitors Production (Kg) Growth Rate Forecast 2019-2025
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Price (USD/g) Forecast 2019-2025
Figure North America Isocitrate Dehydrogenase Inhibitors Production Growth Rate Forecast 2019-2025 (Kg)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Isocitrate Dehydrogenase Inhibitors Production Growth Rate Forecast 2019-2025 (Kg)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Isocitrate Dehydrogenase Inhibitors Production Growth Rate Forecast 2019-2025 (Kg)
Figure China Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Isocitrate Dehydrogenase Inhibitors Production Growth Rate Forecast 2019-2025 (Kg)
Figure Japan Isocitrate Dehydrogenase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (Kg) of Isocitrate Dehydrogenase Inhibitors by Type (2019-2025)
Table Global Consumption (Kg) of Isocitrate Dehydrogenase Inhibitors by Application (2019-2025)
Table Isocitrate Dehydrogenase Inhibitors Distributors List
Table Isocitrate Dehydrogenase Inhibitors Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources